Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CBC Healthcare Infrastructure Platform acquires prime industrial land in Shanghai to develop a high-specifications life science park 2022-11-01 11:00
CARsgen Appoints Dr. Sylvie Peltier as Senior Vice President of Global Regulatory Affairs 2022-10-31 21:30
Announcement of the Effect of Ginseng and Red Ginseng for Memory Improvement and Suppression of Bone and Muscle Loss 2022-10-31 21:08
Gracell Biotechnologies to Report Third Quarter 2022 Financials on Monday, November 14, 2022 2022-10-31 21:00
Senhwa Announces First Patient Successfully Dosed in Phase I Study of Pindnarulex in Combination with Pfizer's Talazoparib for the Treatment of Prostate Cancer 2022-10-31 19:00
Akeso Announces Oral Presentation of Ivonescimab (PD-1/VEGF Bi-Specific) in First-line Treatment of ES-SCLC on ACLC 2022 2022-10-31 08:40
GenesisCare and PreludeDx(TM) present compelling Australian-first DCISionRT Study Interim Analysis during Breast Cancer Awareness Month 45% change in treatment recommendations when using DCISionRT 2022-10-31 05:00
Nuevocor to Present Pre-clinical Data on its Gene Therapy Candidate for LMNA Dilated Cardiomyopathy at American Heart Association Scientific Sessions 2022 2022-10-28 22:30
LISCure Biosciences Announces Oral Presentation of New Drug Candidate for NASH at Upcoming AASLD The Liver Meeting 2022 2022-10-28 21:00
Hinova Disclosed the Preclinical Results of HP518 (Oral AR PROTAC) at the 5th Annual TPD Summit 2022-10-28 20:30
Novel, Biocompatible UV Light Absorber: WPI-MANA 2022-10-28 14:00
NDA for New Second-Line Indication of CAR T-Cell Therapy Product YIKAIDA (Axicabtagene Ciloleucel Injection) Approved for CDE Review 2022-10-28 01:37
WuXi Biologics Provides Corporate Updates 2022-10-27 22:13
Simcere Receives FDA Clearance of Investigational New Drug Application (IND) for Bi-functional Fusion Protein, SIM0237 2022-10-27 21:25
Kintor Pharma Announces Completion of Subject Enrollment and Dosing in Phase I Clinical Trial of AR-PROTAC(GT20029) in the US 2022-10-27 21:22
Happiness Development Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement 2022-10-27 20:00
Tsinghua SIGS Virtual Open Day 2023 | Where your future starts 2022-10-27 16:59
Antengene to Host Research and Development Day on November 15th and 17th, 2022 2022-10-27 11:07
Cali Biosciences Announces Publications of Phase IIa Results of Long-Acting Ropivacaine (CPL-01) 2022-10-27 10:07
Samsung Biologics Reports Third Quarter 2022 Financial Results 2022-10-27 07:35
1 132 133 134 135 136 812